What is the Impact Factor of Alzheimers Research & Therapy?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Alzheimers Research & Therapy is 8.90, ranking in quartile Q1 of Web of Science (SCIE).

Is Alzheimers Research & Therapy indexed in Web of Science or Scopus?

Yes, Alzheimers Research & Therapy is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 2.479 (Q1) and an H-index of 123.

Who publishes Alzheimers Research & Therapy and what is the Article Processing Charge (APC)?

Alzheimers Research & Therapy is published by BioMed Central. The estimated Article Processing Charge (APC) is approximately $3,957 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Alzheimers Research & Therapy?

The official ISO-4 abbreviation of Alzheimers Research & Therapy is "ALZHEIMERS RES THER" with common acronym "azrt". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #988Top JournalHybrid

Alzheimers Research & Therapy

Acronym:azrt

•

Abbreviation (ISO):ALZHEIMERS RES THER

•

Identifier (ISSN):1758-9193(Print)

•

Publisher:BioMed Central

Official Website Submission Portal Compare

Clarivate IF (2026)

8.9↑ +1.3

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIETop Tier

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Alzheimers Research & Therapy

WoS Q1

Annual Impact Factor Metric

Current (2026):8.9

Scopus SJR & RankScopus Q1

2.479

#988

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

123

123 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier

Self-Citation Rate2.5%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

195articles/year

99.87% Gold OA•91.15% Original Research

Aims & Scope

Alzheimer's Research & Therapy is the major forum for translational research into Alzheimer's disease and the leading open access journal in the field. Affiliated to Alzheimer's Disease International (ADI), it publishes open access basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies. The journal also provides reviews, viewpoints, commentaries, debates and reports. Although the primary focus is Alzheimer's dementia, the scope encompasses translational research into other neurodegenerative diseases.

Topics Covered (Recognized by AI)

Medicine99%Internal medicine96.4%Pathology93.5%Biology93%Disease86.9%Psychology80.6%Neuroscience68%Dementia58.7%Psychiatry54%Chemistry51.2%Genetics49%Biochemistry45.8%Alzheimer's disease41%Cognition38%Mathematics33.2%Statistics28.6%Endocrinology25.4%Radiology20.7%

Primary Research Areas

Medicine

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

CLINICAL NEUROLOGY

Rank13/296

IndexSCIE

JCRSCIE2026

NEUROSCIENCES

Rank18/330

IndexSCIE

JCISCIE2026

CLINICAL NEUROLOGY

Rank11/296

IndexSCIE

JCISCIE2026

NEUROSCIENCES

Rank12/330

IndexSCIE

Category	Index	Rank	Quartile
CLINICAL NEUROLOGY	JCRSCIE	13/296	Q1
NEUROSCIENCES	JCRSCIE	18/330	Q1
CLINICAL NEUROLOGY	JCISCIE	11/296	Q1
NEUROSCIENCES	JCISCIE	12/330	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF8.9

Articles / Year234

Total Citations122

2025

IF7.6

Articles / Year292

Total Citations2,373

2024

IF7.9

Articles / Year279

Total Citations5,130

2023

IF9

Articles / Year221

Total Citations5,637

2022

IF8.823

Articles / Year202

Total Citations8,188

Year	Impact Factor	Articles / Year	Total Citations
2026	8.9	234	122
2025	7.6	292	2,373
2024	7.9	279	5,130
2023	9	221	5,637
2022	8.823	202	8,188
2021	6.982	203	11,484
2020	6.116	168	11,258
2019	6.142	115	9,032
2018	5.015	127	8,381
2017	—	101	9,313
2016	—	59	5,647
2015	—	80	6,903

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #988Scopus Q1SCImago Profile

Scopus Coverage:2010-2026

•

Scopus Broad Areas:MedicineNeuroscience

Scopus Citation Rank (SJR)Q1

2.479

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

7.82

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,957 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations5,861

3-Year Documents676

Citable Documents666

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)2

Citations in government and international policy documents

Female Author Rate47.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cognitive NeuroscienceQ1

NeurologyQ1

Neurology (clinical)Q1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 2.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

1区 (Zone 1)Medicine

Minor Category (Specific Field):

1区CLINICAL NEUROLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Alzheimers Research & Therapy (acronym: azrt, abbr: ALZHEIMERS RES THER, ISSN: 1758-9193) is a peer-reviewed international scholarly journal in the field of Medicine, published by BioMed Central in United Kingdom since 2009. The periodical holds a Journal Impact Factor (JIF) of 8.90, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 2.479 (Q1), an H-index of 123.

The journal enforces rigorous peer evaluation with an annual output of approximately 195 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,957 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.